$RLX

SEI takes new $687K stake in vape maker RLX as earnings miss

Sei Investments Co. bought 312,471 shares of RLX Technology Inc. worth about $687,000 in Q1, according to HoldingsChannel.com. RLX reported Aug. 14 EPS of $0.03 versus $0.09 expected and revenue of $148.73 million versus $173.99 million. Weiss reiterated a hold, with an average $2.50 target.

Original reporting
Published Aug 15, 2026, 9:16 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SEI takes new $687K stake in vape maker RLX as earnings miss — source image
Decision brief

The 30-second read

$RLXNeutralMed
01

Why it matters

The trade setup is a tug-of-war between a fresh institutional stake (SEI) and a negative earnings/revenue surprise (EPS and revenue below consensus).

02

Market read

Traders get a fresh flow signal (SEI stake) but must weigh it against a recent earnings and revenue miss that can dominate near-term price action.

03

What to watch

The article cites stake changes from HoldingsChannel and does not confirm the intent, horizon, or whether other holders are reducing exposure after the earnings miss.

Relevance 6/10Novelty 5/10Timing: pre-market today (Aug. 15) after Aug. 14 earnings miss

Background

RLX is a China-based closed-pod vaping and prefilled cartridge company, operating in a tightly regulated market.

Company-level read

Ticker impact

$RLXNeutralMedium confidence
Context

SEI Investments bought 312,471 RLX shares worth about $687K, while RLX just reported an earnings and revenue miss on Aug. 14.

Expected impact

Likely modest support for RLX shares, but follow-through depends on whether demand stabilizes after the earnings and revenue miss.

Evidence & confidence

The article provides a fresh stake entry by SEI and specific earnings/revenue shortfalls, which can offset each other in the short term.

Market effects

Highlights ongoing uncertainty in China’s tightly regulated vaping market, where results can diverge from investor positioning.

China consumer/regulated product names may see sentiment swings tied to quarterly prints and institutional flows.

Limited spillover beyond vaping peers unless the buying trend broadens across the sector.

Counterpoint

SEI’s small stake size relative to RLX’s market cap may be more informational than conviction, so it may not prevent further downside if fundamentals deteriorate.

Key entities

  • RLX Technology Inc.

    Closed-pod vaping devices and prefilled cartridges provider; reported EPS $0.03 vs $0.09 consensus and revenue $148.73M vs $173.99M on Aug. 14.

  • Sei Investments Co.

    Acquired a new stake in RLX during Q1, buying 312,471 shares worth about $687K.

  • Canada Pension Plan Investment Board

    Lifted its RLX stake 53.7% in Q2 to 3,804,284 shares worth $8.407M.

  • JPMorgan Chase & Co.

    Boosted its RLX holding by 11,091.5% in Q3 to 808,589 shares.

Related articles

$RLXMed

RLX Technology (RLX) Bets Big On Europe And Nicotine Pouches

RLX Technology (RLX) reported Q2 2026 revenue of RMB1.01B (+14.8% YoY), with international sales at 70% of revenue. Gross margin expanded to 35.4% due to supply chain and product mix improvements. The company acquired a 51% stake in a European distributor, aiming to build direct retail relationships. However, China revenue is expected to be flat for the year due to regulatory tightening. RLX is also investing in nicotine pouches and has RMB13.9B in capital resources.

$RLXMedAI 8/10

RLX Technology (RLX) Q2 2026 Earnings Call Transcript

RLX Technology reported Q2 2026 net revenue of RMB 1,010.5 million, up 14.8% YoY, driven by international expansion and a 2025 acquisition. Gross margin expanded to 35.4% from 27.5% YoY. International sales contributed 70% of revenue. Non-GAAP income from operations rose 28.8% YoY to RMB 149.6 million. GAAP net income increased 1.6% YoY to RMB 222.0 million. Management highlighted growth in oral nicotine pouches and a 51% investment in a European distributor.

$RLXMed

RLX Technology Inc. (RLX): Financial results for Q2 2026

RLX Technology Inc. (RLX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 RLX Technology Announces Unaudited Second Quarter 2026 Financial Results SHENZHEN, August 14, 2026 /PRNEWSWIRE/ - RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced its unaudited financial re

$RLXMedAI 8/10

Robust Earnings and International Expansion Assert RLX Technology Inc. (RLX) as a Top Sin Stock to Buy

RLX Technology (NYSE:RLX) reported first-quarter results on May 20 that beat expectations, driven by international expansion. Net revenues rose 96.2% to $229.9 million and gross margin improved to 31.8% from 28.6%. Adjusted net income increased 41.4% to $51.8 million, with adjusted EPS of $0.038. International operations were 72.3% of revenue, led by Europe and Asia.